VASTHERA Co.Ltd.
- Biotech or pharma, therapeutic R&D
VASTHERA Co., Ltd. is a Korea-based, pre-clinical stage pharmaceutical company pioneering first-in-class small molecule drugs for cardiovascular diseases, neurodegenerative diseases, and cancers through its proprietary drug discovery platform, Redoxizyme™, which enables the generation of small molecules targeting redox signaling pathways critical to the onset and pathogenesis of these diseases.



